A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032)

NCT03882996 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

432

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Ezetimibe
DRUG: Atorvastatin

Sponsor

Organon and Co